ARV Procurement Working Group

Our Contacts

Business Online, Newyork, 1st block
1234 Building no 8, floor 3

Phone: 5586 554 558

APWG supports the ARV market in low- and middle-income countries through procurement, strategically managed demand and reduced fragmentation.‚Äč

Lopinavir/Ritonavir 40mg/10mg Pellets and Granules and 100/25 mg Tablets

Due to the increasing uptake of paediatric LPV/r formulations, the ARV Procurement Working Group (APWG) has developed the below dashboard to provide information on supply availability in the coming 18-months.

Recommendations for country programs:


  • Countries are strongly discouraged from stockpiling LPV/r oral pellets or oral granules and instead advised to plan for more frequent, staggered small deliveries of large orders;
  • Available supply is expected to increase towards the beginning of 2020,till that time countries are encouraged to plan for a six to nine months delivery lead time from order placement to delivery;
  • Closely monitor the rate of LPV/r oral pellet or oral granule uptake and update forecasts on a frequent basis;
  • Develop clear eligibility criteria which prioritizes paediatric formulations for the appropriate populations. Current recommendation for children >10kg who can swallow should be transitioned to the 100/25mg tablets;
  • More info:

Lopinavir/Ritonavir supply availability


Procurement and Delivery Planning Guide

Create a website